Core Quantum Technologies, Inc.

COLUMBUS, OH · Founded 2012 · Biotech · Private

Magnetic-fluorescent nanoparticle reagents for cell separation and flow cytometry analysis of tissue samples

Claim this profile

Follows are private to you and power your alerts

Updated · corequantum.com

Sector
Biotech
Headquarters
COLUMBUS, OH
Founded
2012
Latest Form D
$150K, Nov 2014
Total capital
$1.3M
Federal grants
$1.1M
2 awards · 2018–2019
Rank in peer group#270 of 326
Private capital raised
$150K
1 Form D · last Nov 2014
143 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
2 pending · first 2025
Rank in peer group#80 of 326

Capital timeline

201420152016201720182019FEDERAL ↑EQUITY ↓Cumulative $1.3M$225K$900K1st Form D$150K
201420152016201720182019FEDERAL ↑EQUITY ↓Cumulative $1.3M$225K$900K1st Form D$150K

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: Magnetic Quantum Dots for Cell Separation and Characterization$900K
  • Federal grantNSF · Phase I · SBIR Phase I: Magnetic Quantum Dots for Cell Separation and Characterization$225K
  • Private capital raisedForm D · SEC · 1st filing$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 326 peers

Line = median

Biotech · Molecule

  • Federal grantsBelow median
  • Granted patents#80 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Gang RuanDirectorNamed in SEC Form D filings
  • Ian HarrisDirectorNamed in SEC Form D filings
  • Jessica WinterExecutive Officer, DirectorNamed in SEC Form D filings
  • Kristie MelnikExecutive Officer, DirectorNamed in SEC Form D filings
  • Kunal ParikhDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 3
  • PendingPolymer Composite Nanomaterial Encapsulation SystemUSPTOApplication 19251037
  • GrantedPolymer Composite Nanomaterial Encapsulation SystemUSPTOUS 12,370,266
  • PendingPolymer Composite Nanomaterial Encapsulation SystemUSPTOApplication PCTUS2023030594
  • Core Quantum TechnologiesShares a founder: Qirui Fan
  • Aldeyra TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Thunder Biotech, Inc.Similar federal contract value in Biotech · null in contracts
  • Trait Biosciences Inc.Similar federal contract value in Biotech · null in contracts
  • GENVAX TECHNOLOGIES INCSimilar federal contract value in Biotech · null in contracts
  • Pfenex Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .